Literature DB >> 27882396

Athina Markou's contributions to treatment development for mental illnesses: a perspective.

Lois Winsky1, Linda S Brady2.   

Abstract

Entities:  

Year:  2016        PMID： 27882396     DOI： 10.1007/s00213-016-4485-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

Review 1.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.

Authors:  David A Slattery; Athina Markou; Wolfgang Froestl; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

3.  Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations.

Authors:  A Markou; G F Koob
Journal:  Physiol Behav       Date:  1992-01

4.  The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.

Authors:  Nikolaos Pitsikas; Athina Markou
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

Review 5.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

6.  Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

Authors:  Xia Li; Victoria B Risbrough; Chelsea Cates-Gatto; Katarzyna Kaczanowska; M G Finn; Amanda J Roberts; Athina Markou
Journal:  Neuropharmacology       Date:  2013-01-29       Impact factor: 5.250

7.  The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.

Authors:  Vasilios Grivas; Athina Markou; Nikolaos Pitsikas
Journal:  Eur J Pharmacol       Date:  2013-06-11       Impact factor: 4.432

Review 8.  Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2013-10-14       Impact factor: 4.600

9.  Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research.

Authors:  A Der-Avakian; M S D'Souza; D A Pizzagalli; A Markou
Journal:  Transl Psychiatry       Date:  2013-08-27       Impact factor: 6.222

10.  Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.

Authors:  Raveendra-Panickar Dhanya; Douglas J Sheffler; Russell Dahl; Melinda Davis; Pooi San Lee; Li Yang; Hilary Highfield Nickols; Hyekyung P Cho; Layton H Smith; Manoranjan S D'Souza; P Jeffrey Conn; Andre Der-Avakian; Athina Markou; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2014-05-09       Impact factor: 7.446
  10 in total
  1 in total

1.  In Memory of Athina Markou (1961-2016): Obituary.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2017-05       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.